BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6199509)

  • 21. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
    Pasamontes L; Egger D; Bienz K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.
    Wychowski C; van der Werf S; Siffert O; Crainic R; Bruneau P; Girard M
    EMBO J; 1983; 2(11):2019-24. PubMed ID: 6196195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for common, intertypic antigenic determinants on poliovirus capsid polypeptides.
    Blondel B; Crainic R; Akacem O; Bruneau P; Girard M; Horodniceanu F
    Virology; 1982 Dec; 123(2):461-3. PubMed ID: 6184881
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
    Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
    J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies.
    Uhlig H; Dernick R
    Virology; 1988 Mar; 163(1):214-7. PubMed ID: 2831657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
    Emini EA; Ostapchuk P; Wimmer E
    J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
    Evans DM; Minor PD; Schild GS; Almond JW
    Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybridoma antibodies to poliovirus N and H antigen.
    Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
    Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
    [No Abstract]   [Full Text] [Related]  

  • 34. Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies.
    Borrego B; García-Ranea JA; Douglas A; Brocchi E
    J Gen Virol; 2002 Jun; 83(Pt 6):1387-1395. PubMed ID: 12029154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigens to viral capsid and non-capsid proteins are present in brain tissues and antibodies in sera of Theiler's virus-infected mice.
    Cameron K; Zhang X; Seal B; Rodriguez M; Njenga MK
    J Virol Methods; 2001 Jan; 91(1):11-9. PubMed ID: 11164481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic sites on type 2 poliovirus.
    Patel V; Ferguson M; Minor PD
    Virology; 1993 Jan; 192(1):361-4. PubMed ID: 7685967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pH-dependent antigenic conversion of empty capsids of poliovirus studied with the aid of monoclonal antibodies to N and H antigen.
    Rombaut B; Vrijsen R; Brioen P; Boeyé A
    Virology; 1982 Oct; 122(1):215-8. PubMed ID: 6291235
    [No Abstract]   [Full Text] [Related]  

  • 39. A competition immunoprecipitation assay of unlabeled poliovirus antigens.
    Rombaut B; Jore J; Boeyé A
    J Virol Methods; 1994 Jun; 48(1):73-9. PubMed ID: 7962262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
    Haresnape JM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.